Brief Behavioral Activation Treatment for Depression With Inpatients

Not Applicable

Completed

• Conditions: Depression

• Registration Number: NCT02712918
• Lead Sponsor: Lovisenberg Diakonale Hospital

Brief Summary

The purpose of the current study was to examine Brief Behavioral Activation Treatment for Depressions (BATD) effectiveness, credibility, and acceptability with moderate to severly depressed inpatients. The study is a systematic replication of a randomized controlled trail from 2003, that provided initial support for BATD With inpatients. The current study compared BATD to Treatment as Usual in a randomized controlled trial.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Primary Completion: 2014-10
• Study Completion: 2014-10
• Study First Submitted: 2015-03-09
• Status Verified: 2016-03
• Study First Submitted QC: 2016-03-15
• Last Update Submitted: 2016-03-15
• Study First Posted: 2016-03-18
• Last Update Posted: 2016-03-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

• Moderate to severe depression (BDI-II > 28 Points).
• Admission length of at least 3 days
• Evaluated to benefit from depression treatment by unit psychiatrist.

Exclusion Criteria

• Current psychotic disorder
• Previously diagnosis with psychotic disorder (including Bipolar disorder)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change of Beck's Depression Inventory-II from baseline	Change from baseline (second day of admission) to discharge from the ward (maximum 21 days, expected average of 10 days).

Secondary Outcome Measures

Name	Time	Method
Credibility and Expectancies Questionnaire	Second day of admission. After first sessions of BATD.	Only BATD group
Treatment Evaluation Inventory - Short Form	Prior to discharge from the ward (maximum 21 days, expected average of 10 days)..	Only BATD group